TimesSquare Capital Management LLC raised its stake in shares of Cardlytics, Inc. (NASDAQ:CDLX) by 111.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 176,080 shares of the company’s stock after acquiring an additional 92,640 shares during the quarter. TimesSquare Capital Management LLC owned approximately 0.54% of Cardlytics worth $19,316,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently bought and sold shares of CDLX. Marshall Wace LLP bought a new position in Cardlytics during the 1st quarter valued at $336,000. FMR LLC boosted its stake in Cardlytics by 2.3% during the 1st quarter. FMR LLC now owns 3,284,572 shares of the company’s stock valued at $54,327,000 after acquiring an additional 72,847 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Cardlytics by 12.1% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,096 shares of the company’s stock valued at $442,000 after acquiring an additional 335 shares during the last quarter. California Public Employees Retirement System lifted its position in shares of Cardlytics by 2.0% in the 4th quarter. California Public Employees Retirement System now owns 61,170 shares of the company’s stock worth $8,733,000 after buying an additional 1,182 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of Cardlytics in the 4th quarter worth about $255,000. Hedge funds and other institutional investors own 92.46% of the company’s stock.
In other Cardlytics news, CEO Lynne Marie Laube sold 4,278 shares of the firm’s stock in a transaction dated Wednesday, March 24th. The shares were sold at an average price of $122.52, for a total value of $524,140.56. Also, CFO Andrew Christiansen sold 500 shares of the firm’s stock in a transaction dated Monday, April 12th. The stock was sold at an average price of $109.95, for a total transaction of $54,975.00. Following the completion of the transaction, the chief financial officer now owns 16,597 shares of the company’s stock, valued at $1,824,840.15. The disclosure for this sale can be found here. Insiders sold a total of 58,334 shares of company stock worth $6,389,744 in the last ninety days. Corporate insiders own 4.14% of the company’s stock.
Cardlytics stock opened at $107.59 on Friday. The firm has a market cap of $3.54 billion, a PE ratio of -45.21 and a beta of 2.60. The company has a debt-to-equity ratio of 0.24, a quick ratio of 7.63 and a current ratio of 7.63. The firm’s 50-day moving average is $110.93. Cardlytics, Inc. has a 52 week low of $55.89 and a 52 week high of $161.47.
Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings data on Tuesday, May 4th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.56) by $0.22. The company had revenue of $53.00 million for the quarter, compared to analysts’ expectations of $51.96 million. Cardlytics had a negative net margin of 34.32% and a negative return on equity of 20.85%. The business’s revenue was up 16.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.26) EPS. On average, equities research analysts anticipate that Cardlytics, Inc. will post -1.98 earnings per share for the current year.
Cardlytics, Inc operates an advertising platform within financial institutions digital channels that include online, mobile, email, and various real-time notifications in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.
Featured Article: Fundamental Analysis and Choosing Stocks
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.